Ftse Mib
34.731,31
0,00%
DAX
20.399,16
0,25%
S&P 500
6.084,19
0,82%
NASDAQ
20.034,89
1,77%
Bitcoin
100.618,86
-0,57%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Galectin Therapeutics Inc (GALT) Galectin Therapeutics Inc (GALT) Notizie

Galectin Therapeutics Inc

GALT
2,02
0,09 (4,66%)
12 Dic 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
03/12/202414:05EDGAR2Form ARS - Annual Report to Security Holders
03/12/202414:04EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
03/12/202414:03EDGAR2Form DEF 14A - Other definitive proxy statements
14/11/202414:00EDGAR2Form 8-K - Current report
14/11/202413:55EDGAR2Form 8-K - Current report
14/11/202413:51EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
23/10/202419:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/10/202422:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/10/202422:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202422:10EDGAR2Form 144 - Report of proposed sale of securities
09/9/202414:00EDGAR2Form 8-K - Current report
26/8/202414:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/8/202413:55EDGAR2Form 8-K - Current report
13/8/202413:50EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
05/8/202414:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/8/202414:38EDGAR2Form 3 - Initial statement of beneficial ownership of..
01/8/202413:50EDGAR2Form 8-K - Current report
23/7/202415:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/6/202419:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/5/202413:55EDGAR2Form 8-K - Current report
15/5/202413:50EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
04/3/202418:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202422:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202422:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202422:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202422:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202422:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202422:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202422:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202422:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202422:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202422:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202422:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/1/202417:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202414:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202314:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 1,91 Min: 1,859 Max: 2,00
Chiusura: 1,93

La tua Cronologia

NASDAQ
GALT
Galectin Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network